share_log

Bone Biologics Analyst Ratings

Bone Biologics Analyst Ratings

骨生物製劑分析師評級
Benzinga Analyst Ratings ·  2022/10/18 07:48
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/18/2022 326.14% EF Hutton → $2.25 Initiates Coverage On → Buy
日期 上行/下行 分析公司 目標價格變動 評級變動 之前/當前的評級
2022 年 10 月 18 日 326.14% EF Hutton → 2.25 美元 啓動覆蓋範圍開啓 → 購買

Bone Biologics Questions & Answers

骨生物製劑問題與解答

What is the target price for Bone Biologics (BBLG)?
骨生物製劑(BBLG)的目標價格是多少?

The latest price target for Bone Biologics (NASDAQ: BBLG) was reported by EF Hutton on October 18, 2022. The analyst firm set a price target for $2.25 expecting BBLG to rise to within 12 months (a possible 326.14% upside). 1 analyst firms have reported ratings in the last year.

EF Hutton於2022年10月18日公佈了骨生物製劑(納斯達克股票代碼:BBLG)的最新目標股價。該分析公司將目標股價定爲2.25美元,預計BBLG將在12個月內升至12個月內(可能上漲326.14%)。1家分析公司去年公佈了評級。

What is the most recent analyst rating for Bone Biologics (BBLG)?
Bone Biologics(BBLG)的最新分析師評級是多少?

The latest analyst rating for Bone Biologics (NASDAQ: BBLG) was provided by EF Hutton, and Bone Biologics initiated their buy rating.

EF Hutton提供了Bone Biologics(納斯達克股票代碼:BBLG)的最新分析師評級,Bone Biologics啓動了買入評級。

When is the next analyst rating going to be posted or updated for Bone Biologics (BBLG)?
Bone Biologics(BBLG)的下一次分析師評級將在何時發佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bone Biologics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bone Biologics was filed on October 18, 2022 so you should expect the next rating to be made available sometime around October 18, 2023.

分析師在進行了廣泛的研究後得出了股票評級,其中包括瀏覽公開財務報表,與Bone Biologics的高管和客戶交談,以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級,因此每家公司每年應該獲得4次評級。Bone Biologics的最新評級是在2022年10月18日發佈的,因此您應該預計下一個評級將在2023年10月18日左右公佈。

Is the Analyst Rating Bone Biologics (BBLG) correct?
分析師對骨生物製劑的評級(BBLG)是否正確?

While ratings are subjective and will change, the latest Bone Biologics (BBLG) rating was a initiated with a price target of $0.00 to $2.25. The current price Bone Biologics (BBLG) is trading at is $0.53, which is within the analyst's predicted range.

儘管評級是主觀的,並且會發生變化,但最新的骨生物製劑(BBLG)評級是啓動的,目標股價爲0.00美元至2.25美元。Bone Biologics(BBLG)目前的交易價格爲0.53美元,在分析師的預測區間內。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論